New MAA: First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma

Bull Cancer. 2021 Oct 12:S0007-4551(21)00374-X. doi: 10.1016/j.bulcan.2021.07.010. Online ahead of print.NO ABSTRACTPMID:34654542 | DOI:10.1016/j.bulcan.2021.07.010

Source: Bulletin du Cancer - October 16, 2021 Category: Cancer & Oncology Authors: Quentin Laune Solenn Brosseau Source Type: research